Clinical Trials Directory

Trials / Completed

CompletedNCT04924673

Impact of the COVID-19 Epidemic on Glycemic Balance and the Level of Stress in Diabetic Patients

Study of the Changes in Glycemic Control and Psychological Distress in Diabetic Patients After the Confinement Period Related to the COVID-19 Epidemic

Status
Completed
Phase
Study type
Observational
Enrollment
202 (actual)
Sponsor
Rennes University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Prospective, non-interventional, multicentric study

Detailed description

The rapid spread of the COVID-19 pandemic and the isolation at home implemented in France, creates unprecedented challenges for diabetic patients. Patients with diabetes have been considered to be at higher risk of infection by the virus, with a greater risk of mortality; this has been a great source of anxiety for them. It is well known that stress has an impact on plasma glucose levels. The French situation where a general confinement has been decreed over the whole territory (which is not the case for all countries) and for a period of two months, makes it possible to study the impact of this unique situation on stress, sedentary lifestyle, changes in diet and decrease in physical activity. There are no similar experiences described in the literature. The investigators hypothesize there will be an increase of HbA1c in the coming months. The main objective is to assess changes in glycemic control in diabetic patients after the confinement period. The secondary objectives are to: * Evaluate the prevalence of a state of psychological distress (which could be described as post-traumatic) following this epidemic situation in a population of patients with diabetes and to determine the main characteristics of patients with such a state of psychological distress. * Study the evolution of the psychological state at a distance from confinement (6 months later) with the same questionnaire. * Analyze characteristics of lifestyle during confinement: food (snacking), frequency of leaving home, sleep disorders and assess a possible association with variations in HbA1c. This is an observational, prospective, multicenter study. Participation in the study will be offered to all consecutive patients seen in Diabetes consultations, who meet the selection criteria.

Conditions

Timeline

Start date
2020-06-17
Primary completion
2021-03-05
Completion
2021-04-22
First posted
2021-06-14
Last updated
2021-06-23

Locations

11 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04924673. Inclusion in this directory is not an endorsement.